AzTrials
AzTrials

Upper Respiratory Tract InfectionsNCT04019730

The Effect of a Ketogenic Diet on the Exercise Induced Immune Response

A study testing diet in people with Upper Respiratory Tract Infections, run by Wageningen University at 2 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

comparing the exercise induced immune response after two weeks on a low carbohydrate (ketogenic) diet with the response after two weeks on a high carbohydrate diet. Read more about this study

Who is it for?
Ages 18 to 45 years, men onlyHealthy volunteers can take part
Conditions the study is for
Upper Respiratory Tract Infections
What is being tested?
diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
2 sitesNetherlands
Study dates
10 Oct 2018to 10 Oct 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Age: 18 - 45 y
  • BMI: 18.5 - 25 kg/m2
  • Hb ≥ 8.5 mmol/L, determined with blood sample from finger tip
  • Minimal of 3 hours of training per week, and a maximum of 10 hours
  • DKTP (diphtheria, pertussis, tetanus and polio) vaccinated (for stimulation of isolated cells (PBMC's) with tetanus toxoid)
Show all 11Show fewer
  • No asthma medication and/or anti-inflammatory medication
  • No use of immunosuppressive medication
  • No flu and/or travel vaccinations in the 4 months before and during the study
  • Able to be present and participate at all test days
  • Willing and able to follow prescribed 2 times a diet for 2 weeks in a row

Who cannot join

  • Chronic illness
  • Food allergies (e.g. nuts, gluten, avocado)
  • Vegetarian diet
  • Blood donations during study or in the 2 months prior to the study
  • Use of immunosuppressive medication
  • Flu and/or travel vaccination 4 months before and during the study
  • Hb < 8.5 mmol/L
  • Working at "Human Nutrition" - Wageningen University

Trial locations and contacts

2 sites in 1 country.

Netherlands2 sites
  • Division of Human Nutrition, Wageningen University

    Wageningen, Gelderland, 6703 HA

  • Wageningen University and research

    Wageningen, Gelderland, 6708 WE

Other trials in Netherlands

About this study

comparing the exercise induced immune response after two weeks on a low carbohydrate (ketogenic) diet with the response after two weeks on a high carbohydrate diet.

Read the detailed description

A cross-over intervention study, with a total duration of 6 weeks. An athlete follows a high, or low carbohydrate (ketogenic) diet. After 2 days a test day takes place where the athlete performs an exercise test and blood samples are taken at different time points. After that, the athlete continues following the diet for another 12 days, after which he comes back again for another identical test day. Then a 2 weeks wash-out period. After that, the athlete follows the same protocol but then with either the low (ketogenic), or high carbohydrate diet.

Being tested
diet
Medical subject headings
Respiratory Tract Infections

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dietOther

    low carbohydrate diet (< 10 EN% carbs) vs high carbohydrate diet (>50 EN% carbs)

Study groups in NCT04019730
Study groupRoleWhat they receive
low carbohydrate dietExperimentalless than 10 En% carbohydrates
Receives: Other: diet
high carbohydrate dietExperimentalmore than 50 En%carbohydrates
Receives: Other: diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PBMC cell differentiation changes in %

    blood samples will be collected before and after exercise, the % of T-cells, NK-T-cells, B-cells, Monocytes in blood will be estimated with flow cytometrie.

    Measured: after 2 days and 2 weeks of adapted diet

Secondary outcomes (3)
  1. stress hormone Cortisol

    blood samples will be collected before and after exercise, the level of cortisol will be estimated in these blood samples

    Measured: after 2 days and 2 weeks of adapted diet

  2. ketone bodies

    in urine will be detected with KetoStix

    Measured: after 2 days and 2 weeks of adapted diet

  3. Free fatty acids

    in blood will be detected with an ELISA

    Measured: after 2 days and 2 weeks of adapted diet

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2019
  2. Study start10 Oct 2018
  3. Primary completion10 Jul 2019
  4. Study completion10 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04019730
Sponsor's protocol ID
NL6540408118
Status last verified
Jul 2019
First submitted
6 Jul 2018
Last updated
19 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing diet in people with Upper Respiratory Tract Infections, run by Wageningen University at 2 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PBMC cell differentiation changes in % (time frame: after 2 days and 2 weeks of adapted diet). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in